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S U M M A R Y
Basidiobolomycosis is a rare fungal disease caused by Basidiobolus ranarum, which is endemic in tropical
and subtropical regions of Africa, Asia, and Latin America. Gastrointestinal basidiobolomycosis poses
diagnostic difﬁculties due to the non-speciﬁc clinical presentation and absence of predisposing factors.
Eight pediatric cases of the disease have been reported recently from Iran, but none of these, or most of
the other cases reported in the literature, has been proven by culture, which is the gold standard method
for diagnosis. We present a case of culture-proven colonic basidiobolomycosis that occurred in a 3-year-
old boy. The outcome was successful following surgical excision and antifungal therapy with
posaconazole.
 2014 The Authors. Published by Elsevier Ltd on behalf of International Society for Infectious
Diseases. 
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Basidiobolomycosis is a rare fungal disease caused by
Basidiobolus ranarum, a fungus belonging to the Entomophthor-
aceae family of the class Zygomycetes. B. ranarum is an
environmental saprophyte with worldwide distribution. The
disease mainly presents as a chronic non-angioinvasive subcuta-
neous infection in immunocompetent individuals.1 Involvement of
the gastrointestinal tract is a rare presentation, which in all
reported cases has posed diagnostic difﬁculties.2,3We report a case
of culture-proven colonic basidiobolomycosis masquerading as
malignancy in a 3-year-old boy.
2. Case report
A 3-year-old boy was referred with a 1-month history of colicky
abdominal pain, nausea, and vomiting. He came from Zahedan,
located in Sistan and Baluchestan Province, Iran. Physical
examination revealed a large tender palpable mass in the right       
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showed anemia (hemoglobin 9.2 g/dl), leukocytosis (12.5  109/l),
eosinophilia (6%), and elevated serum IgE (2034 IU/ml, reference
range <81). A computed tomography (CT) scan showed a mass in
the ascending colon accompanied by adhesion of the bowel loops
to the anterior abdominal wall (Figure 1a). As it was suspected to
be an inﬁltrative process in the colonic wall, the patient underwent
a laparotomy. With a presumptive diagnosis of intestinal tumor,
laparotomy and resection of part of the involved colon was done.
Histopathological examination showed extensive acute and
chronic inﬂammation with foreign body granulomas and numer-
ous eosinophils and neutrophils that involved the entire colonic
wall (Figure 1b). There were also broad, thin-walled septated
fungal hyphae that were surrounded by strongly eosinophilic
material (Splendore–Hoeppli phenomenon) and stained positively
with periodic acid-Schiff (PAS) and Gomori methenamine silver
stains (Figure 1c). These features were suggestive of colonic
basidiobolomycosis. Fungal culture was also consistent with B.
ranarum (Figure 1d).
The patient was treated for 3 months with posaconazole
200 mg every 12 h. The patient’s condition improved and the
disease showed a dramatic response to antifungal treatment. The
antifungal treatment was continued with oral itraconazole for 1
year, with follow-up by abdominal sonography without signs of
relapse.ociety for Infectious Diseases. Open access under CC BY-NC-ND license.
Figure 1. (a) Computed tomography scan showing a mass in the ascending colon accompanied by adhesion of the bowel loops to the anterior abdominal wall (arrow). (b)
Granulomatous inﬂammation of the colonic wall with multinucleated giant cells showing phagocytosed fungal hyphae (arrow); hematoxylin and eosin (100). (c) Periodic
acid-Schiff stain showing septate fungal hyphae (400). (d) Beaked zygospores in cultured material (1000).
N. Zabolinejad et al. / International Journal of Infectious Diseases 22 (2014) 41–43423. Discussion
Gastrointestinal basidiobolomycosis (GIB) is a rare infection
that, unlike other fungal infections, is mainly seen in immuno-
competent hosts. As this fungus is an environmental saprophyte
and is present in soil and decaying vegetables and fruits, the routes
of infection appear to be ingestion of soil or feces or food
contaminated by either of these.1 According to the literature, this
infection is rare; however Geramizadeh et al. recently reported 14
cases from Shiraz, Iran.4 It appears that the small number of
reported cases of GIB is probably related to the limited knowledge
of this disease. Basidiobolomycosis has been reported mainly from
tropical and subtropical areas of the world, as in our case.1–4
Most of the previously reported cases of pediatric GIB have been
male and without any predisposing factors, as was our case. The
main symptoms include fever, abdominal pain, diarrhea, weight
loss, constipation, and an abdominal mass. Peripheral blood
leukocytosis with marked eosinophilia were found in our case,
as in other reported cases.3,4
On physical examination, intra-abdominal masses were always
detected and conﬁrmed by imaging studies, including ultrasonog-
raphy and CT scan, as well as during surgical exploration. Nearly all
reported cases of GIB have shown involvement of the large
intestine. In all cases, a provisional diagnosis of either an
inﬂammatory bowel disease or a malignant process was
suggested.1–3There are many factors that cause difﬁculties in reaching the
diagnosis of GIB, such as the non-speciﬁc clinical presentation,
absence of predisposing or risk factors in patients, non-represen-
tative colonoscopic biopsies due to involvement of non-mucosal
layers of the gastrointestinal tract, and non-speciﬁc inﬂammation
or granulomatous reaction, with possible overlooking of the fungal
hyphae.2,4
The unequivocal diagnosis requires culture of the organism,
which can be isolated from surgically resected tissues. Sabouraud
dextrose agar is a satisfactory medium, and visible growth is
usually present 2–3 days after incubation at 25–30 8C. Colonies are
white to gray with radial folds, and beaked zygospores can be
identiﬁed on microscopic examination of the culture material.2
Although culture is the gold standard for diagnosis, in all reported
pediatric cases from Iran and other countries, fungal cultures were
not done or were negative and the diagnosis was made on the basis
of histological ﬁndings.3,4 Histological examination shows a
granulomatous reaction, admixture of inﬂammatory cells rich in
eosinophils, and the presence of radiating eosinophilic granular
material (Splendore–Hoeppli phenomenon) surrounding broad
branching, pleomorphic, and sparsely septated hyphae. Hyphal
structures are silver- and PAS-positive.2,4 The absence of vascular
invasion and a dense eosinophilic inﬁltrate in the lesional tissue
are important ﬁndings in distinguishing this disease from
mucormycosis, which usually shows a dense neutrophilic inﬁltrate
and vascular invasion.
N. Zabolinejad et al. / International Journal of Infectious Diseases 22 (2014) 41–43 43According to the available data, the prognosis of GIB in pediatric
patients is usually favourable.2–4 A few cases of GIB with a fatal
outcome due to disseminated infection have been reported, mostly
in adults.1
Surgical resection of all affected bowel segments and debride-
ment of the involved tissue in combination with prolonged
antifungal therapy appear to be effective.1,3,4 In a large study
including 91 patients with mucormycosis, posaconazole was given
for 30 days in 80% of the subjects. Amongst the enrolled patients,
13 had a complete response at 12 weeks and 42 had a partial
response.5 Our patient responded well to 3 months of posacona-
zole treatment, and a CT scan performed after 4 months
demonstrated complete disappearance of the mass. Treatment
was continued with oral itraconazole for 1 year, and subsequent
follow-up after 1 year revealed a totally asymptomatic image in
our patient.
In conclusion, GIB is a rare and little-known fungal disease that
has non-speciﬁc presenting features in healthy individuals with no
identiﬁable risk factors. It can be misdiagnosed clinically asmalignancy or inﬂammatory disease. This entity should be
considered in the differential diagnosis of patients with abdominal
mass and eosinophilia. Familiarity of both the clinician and
pathologist with this condition, as well as using tissue culture, can
lead to a deﬁnite diagnosis and prevent a fatal outcome.
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